Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 441 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

REVIEW ARTICLE

Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions

Singh Awadhesh Kumar

Year : 2014| Volume: 18| Issue : 6 | Page no: 753-759

   This article has been cited by
 
1 Effects of Spirulina platensis on insulin secretion, dipeptidyl peptidase IV activity and both carbohydrate digestion and absorption indicate potential as an adjunctive therapy for diabetes
J. M. A. Hannan,Prawej Ansari,Shofiul Azam,Peter R. Flatt,Yasser H. A. Abdel Wahab
British Journal of Nutrition. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Targeting type II diabetes with plant terpenes: the new and promising antidiabetic therapeutics
Suchitra K. Panigrahy,Renu Bhatt,Awanish Kumar
Biologia. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Anti-hyperglycaemic activity of H. rosa-sinensis leaves is partly mediated by inhibition of carbohydrate digestion and absorption, and enhancement of insulin secretion
Prawej Ansari,Shofiul Azam,J.M.A. Hannan,Peter R. Flatt,Yasser H.A. Abdel Wahab
Journal of Ethnopharmacology. 2020; : 112647
[Pubmed]  [Google Scholar] [DOI]
4 Invitro modulation of glucagon-like peptide release by DPP-IV inhibitory polyphenol-polysaccharide conjugates of sprouted quinoa yoghurt
Obaroakpo Joy Ujiroghene,Lu Liu,Shuwen Zhang,Jing Lu,Liu Liu,Xiaoyang Pang,Jiaping Lv
Food Chemistry. 2020; : 126857
[Pubmed]  [Google Scholar] [DOI]
5 Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial
Jordan Kraaijenhof,Marcel H. A. Muskiet,Lennart Tonneijck,D. Margriet Ouwens,Mark H. H. Kramer,Daniël H. Raalte,Mark M. Smits
Diabetes, Obesity and Metabolism. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 Development of diarylpentadienone analogues as alpha-glucosidase inhibitor: Synthesis, in vitro biological and in vivo toxicity evaluations, and molecular docking analysis
Maryam Aisyah Abdullah,Yu-Ri Lee,Siti Nurulhuda Mastuki,Sze Wei Leong,Wan Norhamidah Wan Ibrahim,Muhammad Alif Mohammad Latif,Aizi Nor Mazila Ramli,Mohd Fadhlizil Fasihi Mohd Aluwi,Siti Munirah Mohd Faudzi,Cheol-Hee Kim
Bioorganic Chemistry. 2020; 104: 104277
[Pubmed]  [Google Scholar] [DOI]
7 Discovery of Highly Polar ß-homophenylalanine Derivatives as Non-systemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors
Fubao Huang,Mengmeng Ning,Kai Wang,Jia Liu,Wen bo Guan,Ying Leng,Jianhua Shen
Journal of Medicinal Chemistry. 2019;
[Pubmed]  [Google Scholar] [DOI]
8 Protective role of sitagliptin against oxidative stress in a kainic acid-induced status epilepticus in rats models via Nrf2/HO-1 pathway
Chong-Hao Wang,Na Zhu
Drug Development Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
9 The Role of Glucagon-Like Peptide-1 in Energy Homeostasis
Marzieh Salehi,Jonathan Q. Purnell
Metabolic Syndrome and Related Disorders. 2019;
[Pubmed]  [Google Scholar] [DOI]
10 Dynamics of switching, adherence, and persistence of dipeptidyl peptidase-4 inhibitors use: a nationwide cohort study
Richard Ofori-Asenso,Jenni Ilomaki,Ken Lee Chin,Mohsen Mazidi,Ella Zomer,J. Simon Bell,Dianna J. Magliano,Danny Liew
Diabetes Research and Clinical Practice. 2019; : 107909
[Pubmed]  [Google Scholar] [DOI]
11 A comprehensive review of bioactive peptides obtained from animal byproducts and their applications
Julia Bechaux,Philippe Gatellier,Jean-François Le Page,Yoan Drillet,Véronique Sante-Lhoutellier
Food & Function. 2019;
[Pubmed]  [Google Scholar] [DOI]
12 Therapeutic experience of saxagliptin as first add-on after metformin in Indian type 2 diabetes patients: A non-interventional, prospective, observational study (ONTARGET-INDIA)
Sanjay Kalra,Sarita Bajaj,AG Unnikrishnan,ManashP Baruah,Rakesh Sahay,V Hardik,Amit Kumar
Indian Journal of Endocrinology and Metabolism. 2019; 23(3): 312
[Pubmed]  [Google Scholar] [DOI]
13 Sitagliptin protects the cognition function of the Alzheimer’s disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings
Qing Dong,Shuai-Wen Teng,Yue Wang,Feng Qin,Yue Li,Lu-Lu Ai,Hui Yu
Neuroscience Letters. 2019; 696: 184
[Pubmed]  [Google Scholar] [DOI]
14 Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKa pathway
Tian Shen,Bilin Xu,Tao Lei,Lin Chen,Cuiping Zhang,Zhenhua Ni
Experimental and Therapeutic Medicine. 2018;
[Pubmed]  [Google Scholar] [DOI]
15 Effect of sitagliptin, a DPP-4 inhibitor, against DENA-induced liver cancer in rats mediated via NF-?B activation and inflammatory cytokines
Weidong Jiang,Dacheng Wen,Zhaohua Cheng,Yongsheng Yang,Ge Zheng,Fangying Yin
Journal of Biochemical and Molecular Toxicology. 2018; : e22220
[Pubmed]  [Google Scholar] [DOI]
16 Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention
Sin Yee Tan,Joyce Ling Mei Wong,Yan Jinn Sim,Su Sie Wong,Safa Abdelgadir Mohamed Elhassan,Sean Hong Tan,Grace Pei Ling Lim,Nicole Wuen Rong Tay,Naveenya Chetty Annan,Subrat Kumar Bhattamisra,Mayuren Candasamy
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;
[Pubmed]  [Google Scholar] [DOI]
17 The new paradigm for androgenetic alopecia and plant-based folk remedies: 5a-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance
Nicholas John Sadgrove
Journal of Ethnopharmacology. 2018; 227: 206
[Pubmed]  [Google Scholar] [DOI]
18 Two Novel Bioactive Peptides from Antarctic Krill with Dual Angiotensin Converting Enzyme and Dipeptidyl Peptidase IV Inhibitory Activities
Wei Ji,Chaohua Zhang,Hongwu Ji
Journal of Food Science. 2017;
[Pubmed]  [Google Scholar] [DOI]
19 The Antidiabetic Mechanisms of Polyphenols Related to Increased Glucagon-Like Peptide-1 (GLP1) and Insulin Signaling
J. Domínguez Avila,Joaquín Rodrigo García,Gustavo González Aguilar,Laura de la Rosa
Molecules. 2017; 22(6): 903
[Pubmed]  [Google Scholar] [DOI]
20 Purification, identification and molecular mechanism of two dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from Antarctic krill ( Euphausia superba ) protein hydrolysate
Wei Ji,Chaohua Zhang,Hongwu Ji
Journal of Chromatography B. 2017; 1064: 56
[Pubmed]  [Google Scholar] [DOI]
21 Incretin-based therapy: renal effects
Anton Ivanovich Korbut,Vadim Valerievich Klimontov
Diabetes mellitus. 2016; 19(1): 53
[Pubmed]  [Google Scholar] [DOI]
22 Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats
Maha M. El Batsh,Manal M. El Batch,Noha M. Shafik,Ibrahim H. Younos
European Journal of Pharmacology. 2015; 769: 297
[Pubmed]  [Google Scholar] [DOI]
23 Anti-diabetic potential of Urena lobata leaf extract through inhibition of dipeptidyl peptidase IV activity
Yudi Purnomo,Djoko Wahono Soeatmadji,Sutiman Bambang Sumitro,Mochamad Aris Widodo
Asian Pacific Journal of Tropical Biomedicine. 2015; 5(8): 645
[Pubmed]  [Google Scholar] [DOI]
24 Bariatric surgery and diabetes remission: how far have we progressed?
Awadhesh Kumar Singh,Sunil Kumar Kota
Expert Review of Endocrinology & Metabolism. 2015; 10(5): 545
[Pubmed]  [Google Scholar] [DOI]

 

Read this article